MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib.
Secchiero P.
•
Melloni E.
•
Voltan R.
altro
Zauli G.
2012